Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000162738 | SCV000213209 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000198042 | SCV000252981 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000162738 | SCV000682422 | likely benign | Hereditary cancer-predisposing syndrome | 2016-02-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001528426 | SCV001946019 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 12810666) |
Sema4, |
RCV000162738 | SCV002538060 | likely benign | Hereditary cancer-predisposing syndrome | 2021-08-11 | criteria provided, single submitter | curation | |
Ce |
RCV001528426 | SCV004133273 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | ATM: BP4, BP7 |
ARUP Laboratories, |
RCV001528426 | SCV004564234 | likely benign | not provided | 2022-12-23 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589685 | SCV005083936 | benign | Familial cancer of breast | 2024-06-14 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Center for Genomic Medicine, |
RCV004596080 | SCV005089819 | likely benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001528426 | SCV001740164 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001528426 | SCV001809603 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV001528426 | SCV001906006 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001528426 | SCV001959769 | likely benign | not provided | no assertion criteria provided | clinical testing |